The Oncoguard® Liver test detects early-stage HCC with high sensitivity across patient subgroups

July 19, 2022
David J Kim, MD

Illinois Gastro Group

Please join us for this webinar as we:

  1. Learn to understand & differentiate the warning signs with appropriate testing for patients with abnormal liver enzymes.
  2. Learn to identify patients with cirrhosis.
  3. Discover pathways to management and surveillance.
  4. Explore the comorbidities of cirrhosis.